Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Pharmacia & Upjohn continues investigation of oxazolidinones

Oct. 4, 1996

Quinolonyl-carbapenems from P&G

Oct. 4, 1996

Orally active ester-type carbapenem prodrug from Sankyo

Oct. 4, 1996

Novel carbapenem with anti-MRSA activity from Banyu

Oct. 4, 1996

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Cephalosporin-bridged carbacephem combinations evaluated by Roche

Oct. 4, 1996

Combined beta-lactamase inhibitor/antibacterial agent from Roche

Oct. 4, 1996

Bridged carbacephems from Roche for use in combination with cephalosporins

Oct. 4, 1996

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...